Wen-Yao Wang Selected Research

1- ethynyl- 4- hydroperoxy- 1,2,3,4- tetrahydro- 1- naphthol

1/2022

Assessment of causal direction between thyroid function and cardiometabolic health: a Mendelian randomization study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Yao Wang Research Topics

Disease

3	Atrial Fibrillation 01/2022 - 04/2021
2	Heart Failure 01/2022 - 02/2019
2	Myocardial Infarction 01/2022 - 04/2018
1	Hypertension (High Blood Pressure) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Essential Hypertension 01/2022
1	Pulmonary Heart Disease (Cor Pulmonale) 01/2022
1	Stroke (Strokes) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 04/2021
1	Death (Near-Death Experience) 04/2021
1	Systolic Heart Failure 02/2019
1	Hypothyroidism 02/2019
1	Hepatocellular Carcinoma (Hepatoma) 08/2014

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 04/2021 - 02/2019
1	1- ethynyl- 4- hydroperoxy- 1,2,3,4- tetrahydro- 1- naphtholIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Hemoglobins (Hemoglobin)IBA 04/2021
1	CreatinineIBA 04/2021
1	C-Reactive ProteinIBA 04/2021
1	Uric Acid (Urate)IBA 04/2021
1	pro-brain natriuretic peptide (1-76)IBA 02/2019
1	Thyroid HormonesIBA 02/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2018
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 04/2018
1	Biomarkers (Surrogate Marker)IBA 08/2014

Therapy/Procedure

1	Conservative Treatment 04/2021
1	Therapeutics 02/2019